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of collateral vessels and exertion of ischemic preconditioning, but irreversible ischemia 
damages the heart such as necrosis or apoptosis. In the mice head, it is impossible to 
create low coronary flow (reversible) conditions, leading us to use canine hearts. How- 
ever, it has been also difficult o examine the multiple gene expressions in canine hearts. 
To solve this difficulty, we succeeded in the development of canine DNA microarray, and 
tested the ability of this method to distinguish the subtle but essential differences in the 
pathophysiological conditions of the heart. About sixty cardiovascular elated genes were 
cloned using PCR method from our newly developed beagle dog cDNA library, and spot- 
ted on CMToGAPS slides. PCR fragments were chosen to amplify the specific, non-over- 
lapping open-reading frame of each cDNA. Using the arrays, we analyzed the expression 
profile of canine myooardium in two protocols, 1) necrotic myocardium caused by total 
LAD ligation for 3 hours (edual to mice necrosis model), and 2) ischemic myocardium of 
50% LAD blood flow reduction (equal to angina pectoris of human). Three hours after 50 
% coronary flow reduction, cardiovascular elated genes were changed rapidly and the 
number of upregulated genes was much more than the case of complete coronary occlu- 
sion. These genes included ecto-5'-nucleotidase, endothelin-1, PAl-l, AT1 and AT2 
receptors, PKC e. However, in the necrotic tissue, these gene expressions was almost 
lost. This indicates that ischemic damage without necrosis affects the gene expressions 
stronger on the survived myocardium than fatally damaged myocardium. These data 
suggest that canine DNA microarray provides the novel tool to assess the precise molec- 
ular events following the changes in physiological conditions. 
1099-29 Reduction of Myocardial Infarct Size by a HMG CoA- 
Reductase Inhibitor in Normocholesterolemic Rats 
Sebastian Wolfrum, Michael Grimm, Marc Heidbreder, Andreas Dendorfer, Hugo A. 
Katus, James K. Lied, Gert Richardt, Medical Clinic II and Institute of Pharmacology, 
University of L~beck, Ldbeck, Germany, Department of Vascular Medicine, Brigham & 
Women's Hospital, Boston, Massachusetts. 
Backround: In addition to their lipid lowering properties, statins improve endothelial func- 
tion by increasing the activity of endothelial nitric oxide synthase (eNOS). We hypothe- 
sized, that by this mechanism statins may protect he myocardium from ischemic injury. 
Methods: Anaesthetised rats underwent 30 min of coronary artery occlusion (CAd) fol- 
lowed by 180 min of reperfusion. Heart rate and arterial blood pressure were continu- 
ously monitored throughout he expedments. Plasma cholesterol concentrations were 
determined at the end of the experiments. Infarct size was measured by TTC staining 
and expressed as percentage of area at risk. Myocardial eNOS activity was measured by 
arginine to citrulline conversion assay. The rats were pretreated for one week either with 
cerivastatin (0.3 mgkg'ld "1) or placebo. In one set of experiments L-NAME (15 mgkg'l), 
an inhibitor of eNOS, was applicated 15 rain prior to CAd. Results: Cerivaatatin 
increased myocardial eNOS activity by 58% (12 -+ 1 to 19 + 2 pmol/mg/min, p,:0.05) and 
decreased infarct size by 49% (59 ± 7% to 29 ± 5%, p<0,05) without affecting hemody- 
namics or plasma cholesterol evels. Cardioprotection and uprogulation of eNOS activity 
were absent in rats co-treated with L-NAME. Conclusion: Statins reduce the extent of 
myocardial necrosis after acute ischemia/reperfusion i jury by increasing myocardial 
eNOS activity. 
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1099-30 Slmvastatin Restores Endothelial Nitric Oxide Mediated 
Vasorelaxation in Large Arteries After Myocardial 
Infarction 
Kathrvn Bates. Steven Goldman, Mohemed Gaballa, SAVAHCS, Tucson, Arizona. 
Congestive heart failure (CHF) after myocardial infarction (MI) is associated with dimin- 
ished endothelial nitric oxide (NO)-mediated vasorelaxation. The 3-hydroxy-3 methylglu- 
taryl CoA reductase inhibitors have been shown to modulate vascular tone, independent 
of their effects on lipid lowering. We hypothesized that simvastatin restores NO-depen- 
dent vasorelaxation after MI, produced by coronary artery ligation, via uprogulation of 
endothelial nitric oxide synthase (eNOS). We found that compared to normal arterial tis- 
sue incubated with culture medium only, incubation with 0.1 mM of simvastatin for 24 
hours enhanced acetylcholine (ACh)-mediated vasorelaxation (P<0.05) with peak 
observed at 10 ,4 M (60~11% vs 33.7±7.8%, n=6; P<0.05). Compared to untreated rats, 
simvastatin increased eNOS protein content by over 200% (62.0~-t 4.0 % vs 21.6-+7.9 %, 
II/mg protein, P<0.05). In endothelial celts in culture, 10 mM and 20 mM of simvastatin 
increased eNOS Jevels by 114.7±39.9% and 212.0+75.0% H/rag protein, n=6, P<0.05, 
respectively, in CHF rats treated by oral gavage with simvastatin (20 mg/kg/day) for three 
weeks, mean artedal pressure (105 -+ 5.75 vs 96.5 -+ 10.SmmHg) and LV dP/dt (4288 + 
672, vs 4091 -+ 1064 mmHg/sec, N--6) were decreased (P<0.05). Treatment of CHF rats 
with simvastatin reduced basal vasoconstriction and improved (P<0.05) the ACh-medi- 
ated vasorelaxation with a maximal response of 66.8 -+ 5.7% vs 32.6 -+ 6.8%, N=7, 
respectively. Inhibition of NO generation using 100 mM NG-nitro-L-arginine methyl ester 
(L-NAME) abolished the ACh-induced vasorelaxation in all rats. Our data suggest that 
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after 24 hour incubation with simvastatin in thoracic aodic segments and endothelial ceils 
in culture, endothelial dependent vasorelaxation is enhanced via up-regulation of endot- 
helial eNOS. More importanUy, chronic treatment with simvastatin restores endothelial 
NO-dependent dysfunction in heart failure rats. 
1099-31 Inhibitory Effects of the Novel Antagonist of Both GP 
lib/Ilia and Vitronectin Receptors on the Formation of 
Coronary Thromboemboli Caused by an Inhibition of 
Adenosine Receptors During Coronary Hypoperfusion 
in Dogs 
Hiroshi Asanuma, Masafumi Kitakaze, Koichi Node, Shoji Saneda, Hisakazu Ogita, Seiji 
Takashima, Masanori Asakura, Tetsuo Minamino, Michihiko Tada, Masatsugu Hod, 
Osaka University Graduate School of Medicine, Suita, Japan, National Cardiovascular 
Center, Suita, Japan. 
Background: Platelet glycoprotein (GP) lib/Ilia is a membrane receptor for fibrinogen 
and yon Willebrand factor, which plays an important role in platelet aggregation. Intogrin 
(xV~,3, vitronectin receptor, mediates adhesion and migration of many types of cells, such 
as vascular cells, and laukocytes. The activation of platelets and the formation of neutro- 
phU-platelet conjugates may lead to the development of thromboemboli. We have previ- 
ously reported that endogenous adenosine inhibits P-selectin-dependerd formation of 
coronary thromboemboU during hypoperfusion in dogs, we examined whether the CP 
compound, a novel antagonist of both GP lib/Ilia and vitronectin receptors appears to 
inhibit he formation of thromboemboli during coronary hypopeffusion. 
Methods and Results: When 8-sulfophenyltheophylline (8-SPT), an adenosine receptor 
antagonist, was infused during coronary hypopeffusion (18.2 ml/10Qg/min, 20 % of the 
control), coronary blood flow decreased gradually and approached almost zero (3.4 ml/ 
100g/rain) 20 rain after its administration. Histological examination revealed thromboem- 
boll in the small coronary vessels. During hypoperfusion in the presence of 8-SPT, the 
CP compound attenuated both the reduction in coronary blood flow (3.4 to 17.2 ml/100g/ 
min, p<O.05), and the formation of thromboemboli, and improved contractile (fractional 
shodeniog, -7.1 to -1.0 %, p<0.05), and metabolic dysfunction (lactate extraction ratio, - 
70 to -54 %, p<0.05) of the myocardium. 
Conclusion: Thus, we conclude that a novel antagonist of both GP lib/Ilia and vitronec- 
tin receptors attenuates platelet aggregation and the worsening of the severity of myo- 
cardial ischemia caused by the inhibitor of adenosine receptors. There appears the 
linkage between the signals of adenosine receptors and GP lib/Ilia or vitronectin recep- 
tors in platelet or coronary endothelial cells. 
1099-32 Early Microvascular Reflow Status After Infarct 
Reperfusion Determines Outcome of Postinfarction 
Remodeling Independent of Myocardial Salvage 
Frank Sowen, Sina L Moainie, Joseph H. Gorman, III, Ivan Sa~go, T. Sloane Guy, IV, 
Martin St. John-Sutton, L. Henry Edmunds, Robed C. Gorman, University of 
Pennsylvania, Philadelphia, Pennsylvania. 
BACKGROUND: Prompt opening of the infarct related adery is the treatment of choice 
for acute myocardial infarction (MI). A beneficial effect on left vantricular (LV) function 
often results even in patients in which little myocardium is salvage. We hypothesized that 
this phenomenon is dependent on adequate early microvascular perfusion. METHODS: 
Six sheep were subjected to 1 hour of ischemia followed by reperfusion (group 1). Six 
sheep underwent 6 hours of ischemia followed by reperfusion (group 2) and 7 sheep 
were infarcted without reperfusion (control). The ischemic region in all animals was 23% 
of the LV mass at the apex. Microvascular eflow was studied using LV long axis real time 
contrast echooardiography and microsphere injection dudng ischemia, 30 minutes after 
coronary repeffusion and at 2, 5, and 8 weeks. Echocardiography was used to assess 
changes in LV size and regional function throughout he study period. RESULTS: During 
coronary occlusion all animals demonstrated complete microvascular ischemia. After 30 
minutes of coronary reperfusion, group 1 animals demonstrated microvascular eflow of 
the area at risk while group 2 animals demonstrated complete transmural non-reflow. At 
2 weeks, both groups demonstrated complete return of transmural microvascular blood 
flow that persisted throughout he remainder of study. Control animals never achieved 
reflow in the infarct region. The area at risk remained akinetic in all groups throughout the 
study. At eight weeks LV end-systolic volume increased by 134% in control animals and 
by 114% in group 2 but was unchanged in group 1. CONCLUSION: Early microvascular 
reflow dramatically improves post-infarction LV remodeling independent of myocardial 
salvage. 
1099-47 Impaired Healing in Factor Xlll KO Mice After Myocardial 
Infarction Assessed by Magnetic Resonance Imaging 
Matthias Nahrendorf, Kai Hu, Karl-Heinz Hiller, Christiane Waller, Stefan Gattenl(~)hner, 
Gerhard Dickneite, Axel Haase, Wolfgang R. Bauer, Georg Ertl, Medizinische Klinik, 
W(Jrzburg, Germany, Biophysik EP5, WEIrzburg, Germany, 
Background: Clotting factor Xlll has been shown to have a role in wound healing. We 
therefore studied healing after coronary artery ligation in FXIll KO and wild type mice. 
Methods: Magnetic Resonance Imaging was done 2 days after MI in a 7 T-Siospec usin~ 
an ECG-triggered Cine-FLASH-sequence: slice thickness 1 ram, echo-time 1.2 ms, reso- 
lution 230 ram. MI-size, left and right ventdcular (LV&RV) volumes, cardiac output (CO), 
ejection fraction (EF), wall thickness (WT) and -thickening (SWT) and LV mass were 
determined. To minimize bleeding from the thorecotomy wound, FXIII-free fibrin glue was 
applied. 
Results and Conclusion: All FXIII KO mice died within 3 to 5 days after MI, whereas 
wild type mice, that survived surgery, did not die. Dilatation after MI was not different 
between groups, but systolic global and regional function was impaired when compared 
to wildtype. Unchanged RV volumes suggest that hemorrhage from thoracotomy was not 
